{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:31:33Z","timestamp":1786606293338,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Breast cancer is the most frequently diagnosed malignancy and a leading cause of cancer-related mortality among women worldwide. Tumor treating fields (TTFields) are a non-invasive anticancer modality based on low-intensity, intermediate-frequency alternating electric fields. In the present study, a conductive electrode-based TTFields-like in vitro exposure system was used to investigate how electrode material and geometry influence biological responses in breast cancer cells. Specifically, we examined the effects of electrode material (silver, gold, and stainless steel), surface area (0.5 and 1\u00a0cm\n                    <jats:sup>2<\/jats:sup>\n                    ), and number of electrodes (two or four) on the response of human breast cancer cells (MCF-7) to TTFields-like exposure generated using conductive metallic electrodes (150\u00a0kHz, 2\u00a0V\/cm). Cells were exposed once for 15\u00a0min using conductive plate electrodes in direct contact with the culture medium. Treatment outcomes were assessed using flow cytometric analysis of cell viability and apoptosis, quantitative PCR analysis of apoptotic regulators, measurement of total antioxidant capacity (TAC), and inductively coupled plasma mass spectrometry (ICP-MS) to quantify metal ion accumulation. Increasing electrode surface area produced a greater reduction in viable tumor cells than increasing electrode number across all materials. Silver electrodes induced the strongest cytotoxic and apoptotic effects, accompanied by a significant increase in the BAX\/BCL-2 ratio, indicating activation of the mitochondrial apoptotic pathway. Notably, silver electrodes caused smaller reductions in TAC compared with gold and stainless-steel electrodes under equivalent conditions, despite detectable metal ion accumulation. These findings demonstrate that electrode material and surface area are critical determinants of cellular response to TTFields-like exposure, highlighting a balance between anticancer efficacy and oxidative stress in vitro.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-65772-2","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:44:05Z","timestamp":1786603445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of electrode material and geometry to enhance TTFields-like anticancer effects in MCF-7 breast cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Ghada M.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh M.","family":"Shawki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seham","family":"Elabd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevan M.","family":"Fekry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa E.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"65772_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31373\/ejtcm\/130486","volume":"3","author":"S Ali","year":"2020","unstructured":"Ali, S., Buczek, D. & Jassem, J. Changing paradigms in breast cancer treatment. Eur. J. Transl Clin. Med. 3, 53\u201363. https:\/\/doi.org\/10.31373\/ejtcm\/130486 (2020).","journal-title":"Eur. J. Transl Clin. Med."},{"key":"65772_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong, X. et al. Breast cancer: pathogenesis and treatments. Signal. Transduct. Target. Ther. 10, 49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"65772_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-025-02861-0","volume":"16","author":"M Zang","year":"2025","unstructured":"Zang, M., Zhu, S. & Niu, Q. Advancement in tumor treating fields of mechanism, clinical applications, and future directions. Discover Oncol. 16, 1\u201325. https:\/\/doi.org\/10.1007\/s12672-025-02861-0 (2025).","journal-title":"Discover Oncol."},{"key":"65772_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/app131810029","volume":"13","author":"MA Alshahat","year":"2023","unstructured":"Alshahat, M. A., Elgenedy, M. A., Aboushady, A. A. & Williams, M. T. S. Cancer treatment: an overview of pulsed electric field utilization and generation. Appl. Sci. 13, 1\u201334. https:\/\/doi.org\/10.3390\/app131810029 (2023).","journal-title":"Appl. Sci."},{"key":"65772_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-925X-13-29","volume":"13","author":"D Miklav\u010di\u010d","year":"2014","unstructured":"Miklav\u010di\u010d, D., Mali, B., Kos, B., Heller, R. & Ser\u0161a, G. Electrochemotherapy: from the drawing board into medical practice. Biomed. Eng. Online. 13, 29. https:\/\/doi.org\/10.1186\/1475-925X-13-29 (2014).","journal-title":"Biomed. Eng. Online"},{"key":"65772_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/fon.13.235","volume":"10","author":"R Cadossi","year":"2014","unstructured":"Cadossi, R., Ronchetti, M. & Cadossi, M. Locally enhanced chemotherapy by electroporation: Clinical experiences and perspective of use of electrochemotherapy. Future Oncol. 10, 877\u2013890. https:\/\/doi.org\/10.2217\/fon.13.235 (2014).","journal-title":"Future Oncol."},{"key":"65772_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","volume":"33","author":"RV Davalos","year":"2005","unstructured":"Davalos, R. V., Mir, L. M. & Rubinsky, B. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33, 223\u2013231. https:\/\/doi.org\/10.1007\/s10439-005-8981-8 (2005).","journal-title":"Ann. Biomed. Eng."},{"key":"65772_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/TBME.2014.2367543","volume":"62","author":"C Jiang","year":"2015","unstructured":"Jiang, C., Davalos, R. V. & Bischof, J. C. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans. Biomed. Eng. 62, 4\u201320. https:\/\/doi.org\/10.1109\/TBME.2014.2367543 (2015).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"65772_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","volume":"24","author":"EJ Mun","year":"2018","unstructured":"Mun, E. J., Babiker, H. M., Weinberg, U., Kirson, E. D. & Von Hoff, D. D. Tumor-treating fields: a fourth modality in cancer treatment. Clin. Cancer Res. 24, 266\u2013275. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1117 (2018).","journal-title":"Clin. Cancer Res."},{"key":"65772_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.21037\/cco-23-82","volume":"12","author":"T Kutuk","year":"2023","unstructured":"Kutuk, T. et al. Tumor treating fields: Narrative review of a promising treatment modality for cancer. Chin. Clin. Oncol. 12, 64. https:\/\/doi.org\/10.21037\/cco-23-82 (2023).","journal-title":"Chin. Clin. Oncol."},{"key":"65772_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41420-022-01206-y","volume":"8","author":"G Tanzhu","year":"2022","unstructured":"Tanzhu, G. et al. The schemes, mechanisms and molecular pathway changes of tumor treating fields (TTFields) alone or in combination with radiotherapy and chemotherapy. Cell. Death Discov. 8, 416. https:\/\/doi.org\/10.1038\/s41420-022-01206-y (2022).","journal-title":"Cell. Death Discov"},{"key":"65772_CR12","doi-asserted-by":"publisher","first-page":"25979","DOI":"10.1109\/ACCESS.2018.2830883","volume":"6","author":"M Al Ahmad","year":"2018","unstructured":"Al Ahmad, M., AlNatour, Z., Mustafa, F. & Rizvi, T. A. Electrical characterization of normal and cancer cells. IEEE Access. 6, 25979\u201325986. https:\/\/doi.org\/10.1109\/ACCESS.2018.2830883 (2018).","journal-title":"IEEE Access."},{"key":"65772_CR13","doi-asserted-by":"publisher","first-page":"e0222289","DOI":"10.1371\/journal.pone.0222289","volume":"14","author":"CI Trainito","year":"2019","unstructured":"Trainito, C. I. et al. Characterization of sequentially staged cancer cells using electrorotation. PLoS ONE. 14, e0222289. https:\/\/doi.org\/10.1371\/journal.pone.0222289 (2019).","journal-title":"PLoS ONE"},{"issue":"3","key":"65772_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3233\/THC-213096","volume":"30","author":"MM Shawki","year":"2022","unstructured":"Shawki, M. M., Azmy, M. M., Salama, M. & Shawki, S. Mathematical and deep learning analysis based on tissue dielectric properties at low frequencies predict outcome in human breast cancer. Technol. Health Care. 30 (3), 633\u2013645. https:\/\/doi.org\/10.3233\/THC-213096 (2022).","journal-title":"Technol. Health Care"},{"issue":"1","key":"65772_CR15","doi-asserted-by":"publisher","first-page":"vdae032","DOI":"10.1093\/noajnl\/vdae032","volume":"6","author":"N Mikic","year":"2024","unstructured":"Mikic, N. et al. Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose-response relationships. Neurooncol Adv. 6 (1), vdae032. https:\/\/doi.org\/10.1093\/noajnl\/vdae032 (2024).","journal-title":"Neurooncol Adv."},{"key":"65772_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-023-02959-x","volume":"23","author":"AR Smothers","year":"2023","unstructured":"Smothers, A. R. et al. Optimization of tumor-treating field therapy for triple-negative breast cancer cells in vitro via frequency modulation. Cell. Int. 23, 1\u20138. https:\/\/doi.org\/10.1186\/s12935-023-02959-x (2023).","journal-title":"Cell. Int."},{"issue":"20","key":"65772_CR17","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-22-0887","volume":"82","author":"JC Moser","year":"2022","unstructured":"Moser, J. C. et al. The mechanisms of action of tumor treating fields. Cancer Res. 82 (20), 3650\u20133658. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0887 (2022).","journal-title":"Cancer Res."},{"key":"65772_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2478\/raon-2023-0044","volume":"57","author":"X Li","year":"2023","unstructured":"Li, X., Liu, K., Xing, L. & Rubinsky, B. A review of tumor treating fields (TTFields): Advancements in clinical applications and mechanistic insights. Radiol. Oncol. 57, 279\u2013291. https:\/\/doi.org\/10.2478\/raon-2023-0044 (2023).","journal-title":"Radiol. Oncol."},{"issue":"5","key":"65772_CR19","doi-asserted-by":"publisher","first-page":"e1813","DOI":"10.1002\/cnr2.1813","volume":"6","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Therapeutic potential of tumor treating fields for malignant brain tumors. Cancer Rep. (Hoboken). 6(5), e1813. https:\/\/doi.org\/10.1002\/cnr2.1813 (2023).","journal-title":"Cancer Rep. (Hoboken)"},{"key":"65772_CR20","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.3390\/molecules27144384","volume":"27","author":"MM Shawki","year":"2022","unstructured":"Shawki, M. M., El Sadieque, A., Elabd, S. & Moustafa, M. E. Synergetic effect of tumor treating fields and zinc oxide nanoparticles on cell apoptosis and genotoxicity of three different human cancer cell lines. Molecules 27, 4384. https:\/\/doi.org\/10.3390\/molecules27144384 (2022).","journal-title":"Molecules"},{"key":"65772_CR21","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1038\/s41598-018-21755-6","volume":"8","author":"BFE Matar\u00e8se","year":"2018","unstructured":"Matar\u00e8se, B. F. E. et al. Use of SU8 as a stable and biocompatible adhesion layer for gold bioelectrodes. Sci. Rep. 8, 5560. https:\/\/doi.org\/10.1038\/s41598-018-21755-6 (2018).","journal-title":"Sci. Rep."},{"key":"65772_CR22","doi-asserted-by":"publisher","first-page":"21182","DOI":"10.1038\/s41598-023-48245-8","volume":"13","author":"K Le","year":"2023","unstructured":"Le, K., Soltanian, S., Narayana, H., Amir Servati, Servati, P. & Ko, F. Roll-to-roll fabrication of silver\/silver chloride coated yarns for dry electrodes and applications in biosignal monitoring. Sci. Rep. 13, 21182. https:\/\/doi.org\/10.1038\/s41598-023-48245-8 (2023).","journal-title":"Sci. Rep."},{"issue":"2","key":"65772_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13534-021-00189-6","volume":"11","author":"RK Lee","year":"2021","unstructured":"Lee, R. K., Baruah, R. K., Bhamra, H., Kim, Y. J. & Yoo, H. Recent advances in electrode development for biomedical applications. Biomed. Eng. Lett. 11 (2), 107\u2013115. https:\/\/doi.org\/10.1007\/s13534-021-00189-6 (2021).","journal-title":"Biomed. Eng. Lett."},{"key":"65772_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1109\/RBME.2017.2765282","volume":"11","author":"C Wenger","year":"2018","unstructured":"Wenger, C. et al. A review on tumor-treating fields (TTFields): Clinical implications inferred from computational modeling. IEEE Rev. Biomed. Eng. 11, 195\u2013207. https:\/\/doi.org\/10.1109\/RBME.2017.2765282 (2018).","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"65772_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-6649-9-1","volume":"9","author":"ED Kirson","year":"2009","unstructured":"Kirson, E. D. et al. Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med. Phys. 9, 1. https:\/\/doi.org\/10.1186\/1756-6649-9-1 (2009).","journal-title":"BMC Med. Phys."},{"key":"65772_CR26","doi-asserted-by":"publisher","unstructured":"Crowley, L. C., Marfell, B. J., Scott, A. P. & Waterhouse, N. J. Quantitation of Apoptosis and Necrosis by Annexin V Binding, Propidium Iodide Uptake, and Flow Cytometry. Cold Spring Harb Protoc. 11 (2016). https:\/\/doi.org\/10.1101\/pdb.prot087288 (2016).","DOI":"10.1101\/pdb.prot087288"},{"key":"65772_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-61779-080-5_31","volume":"731","author":"S Gl\u03b1y\u03c3he\u03c1","year":"2011","unstructured":"Gl\u03b1y\u03c3he\u03c1, S., G\u03b1\u03b2\u03c1iel, \u03a6. G. & C\u03c1ee, I. A. Me\u03b1\u03c3u\u03c1i\u03bdg ge\u03bde ex\u03c0\u03c1e\u03c3\u03c3io\u03bd \u03c6\u03c1o\u00b5 cell cul\u03c4u\u03c1e\u03c3 \u03b2y qu\u03b1\u03bd\u03c4i\u03c4\u03b1\u03c4ive \u03c1eve\u03c1\u03c3e-\u03c4\u03c1\u03b1\u03bd\u03c3c\u03c1i\u03c0\u03c4\u03b1\u03c3e \u03c0oly\u00b5e\u03c1\u03b1\u03c3e ch\u03b1i\u03bd \u03c1e\u03b1c\u03c4io\u03bd. Me\u03c4ho\u03b4\u03c3 Mol. Biol. 731, 381\u2013393. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_31 (2011).","journal-title":"Me\u03c4ho\u03b4\u03c3 Mol. Biol."},{"key":"65772_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u207b\u2206\u2206CT method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"issue":"4","key":"65772_CR29","doi-asserted-by":"publisher","first-page":"102269","DOI":"10.1101\/pdb.prot102269","volume":"2020","author":"CL Kielkopf","year":"2020","unstructured":"Kielkopf, C. L., Bauer, W. & Urbatsch, I. L. Bradford assay for determining protein concentration. Cold Spring Harb Protoc. 2020 (4), 102269. https:\/\/doi.org\/10.1101\/pdb.prot102269 (2020).","journal-title":"Cold Spring Harb Protoc."},{"key":"65772_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G. & Winer, E. P. Breast cancer treatment: A review. JAMA 321, 288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323 (2019).","journal-title":"JAMA"},{"key":"65772_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"65772_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/cancers15041320","volume":"15","author":"B Kinnel","year":"2023","unstructured":"Kinnel, B., Singh, S. K., Oprea-Ilies, G. & Singh, R. Targeted therapy and mechanisms of drug resistance in breast cancer. Cancers (Basel). 15, 1320. https:\/\/doi.org\/10.3390\/cancers15041320 (2023).","journal-title":"Cancers (Basel)"},{"key":"65772_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","volume":"124","author":"O Rominiyi","year":"2021","unstructured":"Rominiyi, O. et al. Tumour treating fields therapy for glioblastoma: current advances and future directions. Br. J. Cancer. 124, 697\u2013709. https:\/\/doi.org\/10.1038\/s41416-020-01136-5 (2021).","journal-title":"Br. J. Cancer"},{"key":"65772_CR34","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/ijms25052529","volume":"25","author":"E Obrador","year":"2024","unstructured":"Obrador, E. et al. Glioblastoma therapy: past, present and future. Int. J. Mol. Sci. 25, 2529. https:\/\/doi.org\/10.3390\/ijms25052529 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"65772_CR35","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.3390\/cancers14153669","volume":"14","author":"X Guo","year":"2022","unstructured":"Guo, X. et al. Tumor-treating fields in glioblastomas: past, present, and future. Cancers 14, 3669. https:\/\/doi.org\/10.3390\/cancers14153669 (2022).","journal-title":"Cancers"},{"key":"65772_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xcrp.2024.102119","volume":"5","author":"E Mylod","year":"2024","unstructured":"Mylod, E., Conlon, G., Jenkins, E. P. W., Malliaras, G. G. & Gardiner, C. M. Tumor-treating fields increase cytotoxic degranulation of natural killer cells against cancer cells. Cell. Rep. Phys. Sci. 5, 1\u201312. https:\/\/doi.org\/10.1016\/j.xcrp.2024.102119 (2024).","journal-title":"Cell. Rep. Phys. Sci."},{"key":"65772_CR37","doi-asserted-by":"publisher","first-page":"mjac047","DOI":"10.1093\/jmcb\/mjac047","volume":"14","author":"S Shams","year":"2022","unstructured":"Shams, S. & Pate, C. B. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]). J. Mol. Cell. Biol. 14, mjac047. https:\/\/doi.org\/10.1093\/jmcb\/mjac047 (2022).","journal-title":"J. Mol. Cell. Biol."},{"key":"65772_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2142\/biophysico.bppb-v21.0013","volume":"21","author":"N Nasori","year":"2024","unstructured":"Nasori, N., Firdhaus, M., Farahdina, U. & Ula, R. K. Optimizing tumor treating fields for blood cancer therapy: Analysis of electric field distribution and dose density. Biophys. Physicobiol. 21, 1\u201312. https:\/\/doi.org\/10.2142\/biophysico.bppb-v21.0013 (2024).","journal-title":"Biophys. Physicobiol"},{"key":"65772_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1109\/10.102812","volume":"37","author":"DB McCreery","year":"1990","unstructured":"McCreery, D. B., Agnew, W. F., Yuen, T. G. & Bullara, L. Charge density and charge per phase as cofactors in neural injury induced by electrical stimulation. IEEE Trans. Biomed. Eng. 37, 996\u20131001. https:\/\/doi.org\/10.1109\/10.102812 (1990).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"65772_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42234-022-00093-z","volume":"8","author":"DB Green","year":"2022","unstructured":"Green, D. B. et al. Effects of waveform shape and electrode material on kilohertz frequency alternating current block of mammalian peripheral nerve. Bioelectron. Med. 8, 11. https:\/\/doi.org\/10.1186\/s42234-022-00093-z (2022).","journal-title":"Bioelectron. Med."},{"key":"65772_CR41","doi-asserted-by":"publisher","first-page":"e2753","DOI":"10.1038\/cddis.2017.171","volume":"8","author":"M Silginer","year":"2017","unstructured":"Silginer, M. et al. Biological activity of tumor-treating fields in preclinical glioma models. Cell. Death Dis. 8, e2753. https:\/\/doi.org\/10.1038\/cddis.2017.171 (2017).","journal-title":"Cell. Death Dis."},{"key":"65772_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-018-0130-x","volume":"4","author":"E Chang","year":"2018","unstructured":"Chang, E. et al. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell. Death Discov. 4, 113. https:\/\/doi.org\/10.1038\/s41420-018-0130-x (2018).","journal-title":"Cell. Death Discov"},{"issue":"10","key":"65772_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.59278\/cbs.v4i10.65","volume":"4","author":"GFT Putri","year":"2025","unstructured":"Putri, G. F. T. & Nurfatihah, Z. Z. Bax\/Bcl-2 ratio as a golden marker of apoptosis: Molecular mechanisms and regulatory pathways. Int. J. Cell. Biomed. Sci. 4(10), 309\u2013317. https:\/\/doi.org\/10.59278\/cbs.v4i10.65 (2025).","journal-title":"Int. J. Cell. Biomed. Sci."},{"key":"65772_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bioelechem.2019.02.002","volume":"127","author":"P Ruzgys","year":"2019","unstructured":"Ruzgys, P., Novickij, V., Novickij, J. & \u0160atkauskas, S. Influence of the electrode material on ROS generation and electroporation efficiency in low and high frequency nanosecond pulse range. Bioelectrochemistry 127, 87\u201393. https:\/\/doi.org\/10.1016\/j.bioelechem.2019.02.002 (2019).","journal-title":"Bioelectrochemistry"},{"key":"65772_CR45","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1038\/s41598-025-34914-3","volume":"16","author":"MM Eltarahony","year":"2026","unstructured":"Eltarahony, M. M., Abughulah, M. E., Shawki, M. M., Sabry, A. & Fahmy, M. M. Comparative antibacterial and anti-virulence effects of silver ions from electrolysis, silver nanoparticles, and silver nitrate against Pseudomonas aeruginosa and Staphylococcus aureus. Sci. Rep. 16, 4385. https:\/\/doi.org\/10.1038\/s41598-025-34914-3 (2026).","journal-title":"Sci. Rep."},{"key":"65772_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<930::AID-CNCR19>3.0.CO;2-W","volume":"83","author":"T Hanada","year":"1998","unstructured":"Hanada, T. et al. Intracellular accumulation of thallium as a marker of cisplatin cytotoxicity in nonsmall cell lung carcinoma. Cancer 83, 930\u2013935. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19980901)83:5%3C930::AID-CNCR19%3E3.0.CO;2-W (1998).","journal-title":"Cancer"},{"key":"65772_CR47","doi-asserted-by":"publisher","unstructured":"Puente, C. & L\u00f3pez, I. Direct electrochemical synthesis of metal complexes. In: (ed Kharisov, B.) Direct Synthesis of Metal Complexes, Elsevier, 87\u2013141 https:\/\/doi.org\/10.1016\/B978-0-12-811061-4.00003-7 (2018).","DOI":"10.1016\/B978-0-12-811061-4.00003-7"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65772-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:18:59Z","timestamp":1786605539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65772-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["65772"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-65772-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25290"}}